Reuters logo
BRIEF-Bayer says receives FDA approval for label update for Xarelto
October 30, 2017 / 12:07 PM / 22 days ago

BRIEF-Bayer says receives FDA approval for label update for Xarelto

Oct 30 (Reuters) - BAYER AG:

* ‍BAYER RECEIVES FDA APPROVAL FOR XARELTO® 10 MG ONCE DAILY FOR EXTENDED TREATMENT OF VENOUS THROMBOEMBOLISM​ Source text: www.bit.ly/2z44Vt1 Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below